Novo Nordisk (NVO) announced primary results from its Phase 3 cardiovascular outcomes trial of semaglutide, with JPMorgan saying the data is positive for Eli Lilly (LLY) shares

Boeing (BA) announced new orders from Emirates, SunExpress, flydubai, and others, while Bloomberg reported that China is contemplating resuming purchase of the 737 MAX

Tyson Foods (TSN) reported mixed Q4 results, with the company saying it anticipates improved results from foreign operations in 2024

Exxon Mobil (XOM) has begun lithium production in Arkansas

Starbucks' (SBUX) unionized baristas are planning a strike on November 16

Micron (MU) has been sued by Yangtze Memory Technologies for patent infringement, DigiTimes reports

Alibaba (BABA) and JD.com (JD) reported year-over-year sales increases for Singles Day, Bloomberg says

Alphabet (GOOGL) sold off its entire holdings of Lyft (LYFT) and Robinhood (HOOD) last quarter, MarketWatch says

Amazon (AMZN) cut 180 positions in its Games division, Reuters reports

Ford (F) production staff it the company's Louisville assembly and Kentucky truck facilities have voted against a proposed labor agreement, Reuters says

Sundial (SNDL) gains in New York after reporting Q3 results and announcing the renewal of its share repurchase program

Cameco (CCJ) higher in New York after RBC Capital reinstated coverage of the stock with an Outperform rating

Verve Therapeutics (VERV) falls after reporting adverse events in its VERVE-101 study

Golden Heaven (GDHG) plunged after Research Hindenburg disclosed a short position and called the company "another classic 'China Hustle'"

Plug Power (PLUG) lower after Wolfe Research downgraded the stock to Peer Perform

Lifeway Foods (LWAY) reported Q3 results, with CEO Julie Smolyanksy commenting "our strong momentum continued in the third quarter"

Monday.com (MNDY) announced Q4 results, provided guidance for Q4, and raised its FY23 outlook, with co-CEOs Roy Mann and Eran Zinman commenting "Q3 marked another strong quarter for monday.com"

Tower Semiconductor (TSEM) reported Q3 results, with its EPS beating consensus

Broadwind (BWEN) reported Q3 results, with CEO Eric Blashford commenting "We delivered a strong third quarter performance"

Virios Therapeutics (VIRI) announced Q3 results, with EPS higher year-over-year

Edward Jones upgraded Oracle (ORCL) to Buy from Hold without a price target. The firm says the company's transition to a subscription model will drive a sales growth acceleration.

Stifel upgraded Crowdstrike (CRWD) to Buy from Hold with a price target of $225, up from $153, as a new analyst took over coverage of the stock. While Endpoint Security is highly competitive, CrowdStrike has differentiation given its high-efficacy cloud-based endpoint technology, lightweight single-agent architecture, and "massive scale" analyzing over 1 trillion events daily, the firm argues.

Citi upgraded HP Inc. (HPQ) to Buy from Neutral with a price target of $33, up from $31. The firm cites continued improvements in PC ecosystem with inventory digestion completed, significant cost-takeout which is supportive of margins and earnings recovery ahead, and an "undemanding valuations" and potential for higher free cash flow generation to drive higher buybacks for the upgrade.

Bernstein upgraded Booking Holdings (BKNG) to Market Perform from Underperform. The firm says consensus estimates and the stock's valuation "looks unchallenging" and that Booking's buyback commitment will continue to make it a popular stock

Bernstein upgraded TripAdvisor (TRIP) to Outperform from Market Perform. The firm says the key fear of operational deleverage from meta declines has been de-risked with other high-margin revenues able to offset, that allows Viator "to once again be the bull case."

Melius Research downgraded Southwest (LUV) to Sell from Hold with a price target of $19, down from $30. Southwest's strategy to outgrow their issues is "not working" and there are two paths Southwest can take - either move forward with the current plan or reset by slowing growth - both of which pose downside risk, the firm says.

Citi downgraded 2U (TWOU) to Neutral from Buy without a price target. While there is a strong argument that the enterprise of 2U is undervalued, it is increasingly difficult to see how the "Gordian Knot" of overleverage is resolved, the firm tells investors in a research note.

Odeon Capital downgraded Regions Financial (RF) to Hold from Buy with a $17.10 price target. Regions has had good management for a decade now, but it appears that management's reliance on margins above sales is "now creating a problem" as the bank must give up this focus "aligning its pricing to the markets," the firm says.

Barclays downgraded Waters (WAT) to Underweight from Equal Weight with a price target of $230, down from $270. The firm cites a lack of visibility on the instrument down cycle and potential recovery, as well as expectations for continued negative sentiment on instrument names for the downgrade.

UBS downgraded IFF (IFF) to Neutral from Buy with a price target of $78, down from $88. The firm sees less potential for IFF to re-rate in the medium term and sees shares as range-bound with lower earnings vs. prior expectations.

Jefferies initiated coverage of Coca-Cola (KO) with a Hold rating and $62 price target. The firm says that while it has momentum and underlying fundamentals are strong, the stock's current valuation provides limited upside as the looming tax settlement "may put a lid on shares." Jefferies also started coverage of Boston Beer (SAM), Church & Dwight (CHD), and Molson Coors (TAP) with Neutral-equivalent ratings.

Jefferies initiated coverage of PepsiCo (PEP) with a Buy rating and $203 price target. The firm says Pepsi is the most durable business in its coverage, and the most likely to grow earnings high-single digits or better in the next three years. Jefferies also started coverage of Constellation Brands (STZ), Keurig Dr Pepper (KDP), Monster Beverage (MNST), Colgate-Palmolive (CL), Vita Coco (COCO), and Procter & Gamble (PG) with Buy-equivalent ratings.

Jefferies initiated coverage of Clorox (CLX) with an Underperform rating and $117 price target. The company's August cyberattack delays its turnaround and adds uncertainty, the firm tells investors in a research note.

Evercore ISI initiated coverage of WK Kellogg (KLG) with an In Line rating and $13 price target. The firm sees downside risk to the company's revenue and gross margin if consumption trends remain weak.

Truist initiated coverage of Cintas (CTAS) with a Buy rating and $625 price target. A return to normalized pricing increases and moderating input costs could drive upside margin gains and FY26 consensus EPS 10%+ higher, the firm tells investors in a research note.

On Monday, stocks, bonds, and the dollar saw minor moves as traders awaited the latest inflation figures, remarks from Federal Reserve speakers, and results from major retailers.

The S&P 500 remained near its key 4,400 level during a light trading session. The gauge closed little changed after nine positive days in a row - a level of consistency seen less than 1% of the time this century and last seen in 2021. Treasury 10-year yields have fallen below 4.65%. The dollar dropped. After three weeks of losses, oil surpassed $78 per barrel.

The Yen pared losses in early trading on speculation that the Bank of Japan intervened to slow weakness in it's currency.